India approves Russia’s Sputnik V vaccine

Moscow, Apr 13 (EFE).- The Russian-made Sputnik V vaccine against Covid-19 has been approved for emergency use in India, Russian authorities said.

The Russian sovereign wealth fund (RDIF) said India was the 60th country to authorize the jab.

In a late Monday statement, Kirill Dmitriev, the CEO of the wealth fund, said: “We appreciate the decision of India’s regulatory bodies to grant authorization for Sputnik V.

“Approval of the vaccine is a major milestone as Russia and India have been developing an extensive cooperation on clinical trials of Sputnik V in India and its local production.”

India is the most populous country to authorize the jab so far.

It is set to join two vaccines already in use in India — Covaxin and Covishield, the latter being the domestically produced version of the AstraZeneca jab.

Sputnik V has an efficacy rate of 91.6% and prevents all severe cases of Covid-19, according to a study in The Lancet medical journal.

Dmitriev added that the RDIF had created partnerships with a number of Indian pharmaceutical companies to produce the vaccine.

“Over 850 million doses of Sputnik V are going to be produced in India annually, sufficient to vaccinate more than 425 million people around the world,” he said.

The authorization coms as India grapples with a second wave of infections.

On Monday India surpassed Brazil to become the second-most infected nation in the world after the United States.

The Asian nation has registered over 13.5 million cases since the pandemic began.EFE


Related Articles

Back to top button